Norway
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 46.04 M
|
Dec. 31, 2023 | USD 17.56 | 0.15% |
|
Norway |
|
2 |
USD 26.17 M
|
Dec. 31, 2023 | USD 0.19 | -0.80% |
|
Norway |
|
3 |
USD 25.17 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
4 |
USD 24.53 M
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
|
5 |
USD 8.60 M
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
6 |
USD 4.75 M
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
7 |
USD 3.73 M
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
8 |
USD 2.35 M
|
Dec. 31, 2023 | USD 0.27 | 1.85% |
|
Norway |
The Biotechnology company in Norway with the highest Cash and Short-Term Investments is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 46.04 M.
The Biotechnology company in Norway with the lowest Cash and Short-Term Investments is Hofseth BioCare ASA (Oslo Stock Exchange: HBC.OL) at USD 2.35 M.
The top 10 Biotechnology companies in Norway by Cash and Short-Term Investments are Borregaard ASA, Ultimovacs ASA, Photocure ASA, ArcticZymes Technologies ASA, Gentian Diagnostics ASA, Lifecare AS, Navamedic ASA and Hofseth BioCare ASA.
The bottom 10 Biotechnology companies in Norway by Cash and Short-Term Investments are Hofseth BioCare ASA, Navamedic ASA, Lifecare AS, Gentian Diagnostics ASA, ArcticZymes Technologies ASA, Photocure ASA, Ultimovacs ASA and Borregaard ASA.